NCT07177677 - A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

August 30, 2028

Conditions

Autism Spectrum Disorder

Interventions

BIOLOGICAL

hBMMSC

Group 1: 0.5×10\^6 cells/kg (participant's body weight) single dose; Group 2: 1.0×10\^6 cells/kg (participant's body weight) single dose; Group 3: 2.0×10\^6 cells/kg (participant's body weight) single dose.